on MAAT PHARMA (isin : FR0012634822)
MaaT Pharma Announces Participation in Investor and Medical Conferences in September
MaaT Pharma, a late-stage clinical-stage biotechnology company, announces its participation in several events in September 2024. At the Society of Hematologic Oncology Annual Meeting in Houston, Texas, September 4-7, two posters will be presented, focusing on MET therapies for cancers.
Themes include results from gastrointestinal disease treatment programs and hematopoietic cell transplantation studies. These data were shared at the EBMT Annual Meeting in April 2024.
MaaT Pharma will also participate in three investor conferences: HC Wainwright in New York (September 9-11), Forum Lyon Pôle Bourse (September 24) and KBC Securities' Life Sciences in Brussels (September 26).
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MAAT PHARMA news